IR@PKUHSC  > 北京大学药学院  > 化学生物学系
学科主题药学
Design, Synthesis, and Biological Evaluation of 1-[(2-Benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance Profile
Wang, Xiaowei2,3; Zhang, Jianfang4; Huang, Yang1; Wang, Ruiping4; Zhang, Liang2,3; Qiao, Kang2,3; Li, Li2,3; Liu, Chang4; Ouyang, Yabo1; Xu, Weisi1; Zhang, Zhili2,3; Zhang, Liangren; Shao, Yiming1; Jiang, Shibo5,6; Ma, Liying1; Liu, Junyi2,3
刊名JOURNAL OF MEDICINAL CHEMISTRY
2012-03-08
DOI10.1021/jm201506e
55期:5页:2242-2250
收录类别SCI ; IC
文章类型Article
WOS标题词Science & Technology
类目[WOS]Chemistry, Medicinal
研究领域[WOS]Pharmacology & Pharmacy
关键词[WOS]IMMUNODEFICIENCY-VIRUS TYPE-1 ; RT INHIBITORS ; POSITIONAL ADAPTABILITY ; CONFORMATIONAL-CHANGES ; DERIVATIVES ; ANALOGS ; COMPLEX ; BINDING ; RESOLUTION ; THERAPY
英文摘要

Because the emergence of drug-resistant mutants has limited the efficacy of non-nucleoside reverse transcriptase inhibitors (NNRTIs), it is essential to develop new antivirals with better drug resistance and pharmacokinetic profiles. Here we designed and synthesized a series of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils, the HEPT analogues, and evaluated their biological activity using nevirapine and 18 (TNK-651) as reference compounds. Most of these compounds, especially 6b, 7b, 9b, 11b, and 7c, exhibited highly potent anti-HIV-1 activity against both wild-type and NNRTI-resistant HIV-1 strains. Compound 7b, which had the highest selectivity index (SI = 38 215), is more potent than nevirapine and 18. These results suggest that the introduction of a halogen at the C-5 position may contribute to the effectiveness of these compounds against RTI-resistant variants. In addition, meta substituents on the C-6 aromatic moiety could significantly enhance activity against NNRTI-resistant HIV-1 strains. These compounds can be further developed as next-generation NNRTIs with an improved antiviral efficacy and drug-resistance profile.

语种英语
WOS记录号WOS:000301170000038
引用统计
被引频次:33[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/60692
专题北京大学药学院_化学生物学系
北京大学药学院
北京大学第三临床医学院_麻醉科
作者单位1.Fudan Univ, Inst Med Microbiol, Shanghai 200032, Peoples R China
2.Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing 102206, Peoples R China
3.Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, Beijing 100191, Peoples R China
4.Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
5.Capital Med Univ, Coll Pharmaceut Sci, Beijing 100069, Peoples R China
6.Fudan Univ, MOE MOH Key Lab Med Mol Virol, Shanghai Med Coll, Shanghai 200032, Peoples R China
推荐引用方式
GB/T 7714
Wang, Xiaowei,Zhang, Jianfang,Huang, Yang,et al. Design, Synthesis, and Biological Evaluation of 1-[(2-Benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance Profile[J]. JOURNAL OF MEDICINAL CHEMISTRY,2012,55(5):2242-2250.
APA Wang, Xiaowei.,Zhang, Jianfang.,Huang, Yang.,Wang, Ruiping.,Zhang, Liang.,...&Liu, Junyi.(2012).Design, Synthesis, and Biological Evaluation of 1-[(2-Benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance Profile.JOURNAL OF MEDICINAL CHEMISTRY,55(5),2242-2250.
MLA Wang, Xiaowei,et al."Design, Synthesis, and Biological Evaluation of 1-[(2-Benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance Profile".JOURNAL OF MEDICINAL CHEMISTRY 55.5(2012):2242-2250.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wang, Xiaowei]的文章
[Zhang, Jianfang]的文章
[Huang, Yang]的文章
百度学术
百度学术中相似的文章
[Wang, Xiaowei]的文章
[Zhang, Jianfang]的文章
[Huang, Yang]的文章
必应学术
必应学术中相似的文章
[Wang, Xiaowei]的文章
[Zhang, Jianfang]的文章
[Huang, Yang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。